Literature DB >> 16720832

Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.

Paquita Nurden1, Najet Debili, William Vainchenker, Regis Bobe, Raymonde Bredoux, Elisabeth Corvazier, Robert Combrie, Edith Fressinaud, Dominique Meyer, Alan T Nurden, Jocelyne Enouf.   

Abstract

In type 2B von Willebrand disease, there is spontaneous binding of mutated von Willebrand factor (VWF) multimers to platelets. Here we report a family in which severe thrombocytopenia may also be linked to abnormal megakaryocytopoiesis. A heterozygous mutation in the VWF A1 domain gave a R1308P substitution in an interactive site for glycoprotein Ibalpha (GPIbalpha). Electron microscopy showed clusters of platelets in close contact. Binding of antibodies to the GPIbalpha N-terminal domain was decreased, whereas GPIX and GPV were normally detected. In Western blotting (WB), GPIbalpha, alphaIIb, and beta3 were normally present. Proteins involved in Ca(2+) homeostasis were analyzed by quantitating platelet mRNA or by WB. Plasma membrane Ca(2+) ATPase (PMCA)-4b and type III inositol trisphosphate receptor (InsP(3)-R3) were selectively increased. The presence of degradation products of polyadenosine diphosphate (ADP)-ribose polymerase protein (PARP) suggested ongoing caspase-3 activity. These were findings typical of immature normal megakaryocytes cultured from peripheral blood CD34(+) cells with TPO. Significantly, megakaryocytes from the patients in culture produced self-associated and interwoven proplatelets. Immunolocalization showed VWF not only associated with platelets, but already on the megakaryocyte surface and within internal channels. In this family, type 2B VWD is clearly associated with abnormal platelet production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720832     DOI: 10.1182/blood-2006-03-009449

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.

Authors:  Tianyu Guo; Xuejun Wang; Yigong Qu; Yu Yin; Tao Jing; Qing Zhang
Journal:  Stem Cell Investig       Date:  2015-02-14

Review 2.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

3.  Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.

Authors:  Paquita Nurden; Alan T Nurden; Silvia La Marca; Margherita Punzo; Luciano Baronciani; Augusto B Federici
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

4.  Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis.

Authors:  Isabella Pallotta; Michael Lovett; William Rice; David L Kaplan; Alessandra Balduini
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

5.  Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation versus clearance.

Authors:  Kathleen Freson
Journal:  Haematologica       Date:  2019-07       Impact factor: 9.941

6.  LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.

Authors:  Alexandre Kauskot; Sonia Poirault-Chassac; Frédéric Adam; Vincent Muczynski; Gabriel Aymé; Caterina Casari; Jean-Claude Bordet; Christelle Soukaseum; Chantal Rothschild; Valérie Proulle; Audrey Pietrzyk-Nivau; Eliane Berrou; Olivier D Christophe; Jean-Philippe Rosa; Peter J Lenting; Marijke Bryckaert; Cécile V Denis; Dominique Baruch
Journal:  JCI Insight       Date:  2016-10-06

7.  The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Authors:  Jun Ishihara; Ako Ishihara; Richard D Starke; Claire R Peghaire; Koval E Smith; Thomas A J McKinnon; Yoji Tabata; Koichi Sasaki; Michael J V White; Kazuto Fukunaga; Mike A Laffan; Matthias P Lutolf; Anna M Randi; Jeffrey A Hubbell
Journal:  Blood       Date:  2019-04-11       Impact factor: 22.113

8.  Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.

Authors:  Caterina Casari; David S Paul; Sophie Susen; Cécile Lavenu-Bombled; Annie Harroche; Raymond Piatt; Kathryn O Poe; Robert H Lee; Marijke Bryckaert; Olivier D Christophe; Peter J Lenting; Cécile V Denis; Wolfgang Bergmeier
Journal:  Blood Adv       Date:  2018-06-26

Review 9.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

10.  Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome.

Authors:  Catherine Strassel; Anita Eckly; Catherine Léon; Claire Petitjean; Monique Freund; Jean-Pierre Cazenave; Christian Gachet; François Lanza
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.